
|
Indian Journal of Dermatology, Venereology and Leprology
Medknow Publications on behalf of The Indian Association of Dermatologists, Venereologists and Leprologists (IADVL)
ISSN: 0378-6323 EISSN: 0378-6323
Vol. 74, No. 6, 2008, pp. 619-621
|
Bioline Code: dv08253
Full paper language: English
Document type: Report
Document available free of charge
|
|
Indian Journal of Dermatology, Venereology and Leprology, Vol. 74, No. 6, 2008, pp. 619-621
en |
Immune Reconstitution Inflammatory Syndrome
Sharma, Ajay; Makrandi, Smita; Modi, Megha; Sharma, Archana & Marfatia, Yogesh
Abstract
Background: Immune reconstitution inflammatory syndrome (IRIS) is a paradoxical deterioration in clinical status in a patient on antiretroviral treatment (ART) despite satisfactory control of viral replication and improvement of CD4 count. Aim: To study development of IRIS as a part of ART. Methods: Hundred patients on antiretroviral treatment were studied prospectively in the Department of Skin and VD over a period of 2 years. Patients were asked to come if they developed any symptoms or on a monthly basis. They were screened clinically and investigated suitably for evidence of opportunistic infections. Results: Out of 100 patients, 10 patients did not come for follow-up. Twenty (22.2%) out of the 90 patients developed IRIS. Herpes zoster (HZ), herpes simplex virus (HSV), and tuberculosis (TB) were the cases of IRIS seen in the present study. Conclusions: IRIS in terms of HSV/TB is known to accelerate HIV disease progression. Hence early detection and prompt treatment, along with continuation of highly active ART, are of utmost importance.
Keywords
Immune reconstitution inflammatory syndrome, Antiretroviral therapy
|
|
© Copyright 2008 Indian Journal of Dermatology, Venereology and Leprology. Alternative site location: http://www.ijdvl.com
|
|